An Efficacy and Safety Study of Ravulizumab in ALS Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The purpose of the study is to assess the efficacy and safety of ravulizumab for the treatment of adult participants with ALS.
Epistemonikos ID: 891953a96b3b6993df25f3e26b39858dd78fb775
First added on: May 07, 2024